USD 2.14 billion
Urinalysis Test Market Size, Share, Growth Analysis, By Application(Disease Screening, Pregnancy and Fertility), By End User(Hospitals & Clinics, Diagnostic Laboratories, Home Care Setting and Research Laboratories & Institute), By Test(Pregnancy & Fertility Tests, Biochemical Urinalysis, and Sediment Urinalysis), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35I2324 |
Region:
Global |
Published Date: April, 2024
Pages:
220
|Tables:
89
|Figures:
71
Urinalysis Test Market Insights
Global Urinalysis Test Market size was valued at USD 2.14 billion in 2022, USD 2.24 billion in 2023 and is projected to grow USD 3.09 billion by 2031, growing at a CAGR of 4.7% in the forecast period (2024-2031).
The market for urinalysis tests is made possible by growth and advancements in the medical equipment sector, which produces items for pregnancy testing and urinalysis, such as urine analyzers. Due to the availability of improved healthcare infrastructure, an increase in unmet healthcare needs, the rise in the prevalence of chronic diseases like diabetes, and a surge in demand for urine analyzers, strips, and control solutions, the urine test market is expected to grow at a rapid pace in untapped, emerging markets. As a result, the growing number of diabetics has raised demand for urine tests, driving the market's expansion.
Governments also conduct screening programmes to help discover diseases like renal and urological issues early. For example, the National Institute of Health (NIH) reports that 12,497 schoolchildren from Pingyang, Cangnan, and Yongjia in Wenzhou had urine screening between February 2012 and March 2021. As a result, it is anticipated that an increase in these programmes will fuel the market for urine tests. One of the most prevalent types of illnesses, urinary tract infections can affect both men and women. The need for urinalysis testing is being driven by the rising incidence of urinary tract infections, which are used to identify diabetes, various renal problems, and other conditions.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Pregnancy & Fertility Tests
Fastest Growth
Biochemical Urinalysis
Growth Rate
4.7% CAGR
Global Urinalysis Test Market ($ Bn)
Country Share for North America (%)
To get more reports on the above market click here to Buy The Report
Urinalysis Test Market Segmental Analysis
The global urinalysis test market is segmented based on application type, end user type, test and regional type. In terms of application, the market is segmented into disease screening, pregnancy and fertility. Based on end user, the market is bifurcated into hospitals & clinics, diagnostic laboratories, home care setting and research laboratories & institute. Based on tests, the market is bifurcated into pregnancy & fertility tests, biochemical urinalysis and sediment urinalysis. Based on region, the market is segmented into North America, Europe, Asia Pacific, Central & South America and Middle East & Africa. For the most part, the diagnostic goods' technological developments have given the tests category the highest market share.
Analysis by Test
As per categorization by test, the market is classified into pregnancy & fertility tests, biochemical urinalysis and sediment urinalysis. Among these, pregnancy & fertility tests earned the largest share and continue to dominate the market. The improvement of accuracy, usability, and accessibility has been the main emphasis of innovation in pregnancy and fertility tests within the global urinalysis test industry. Modern technology that makes monitoring and interpreting findings easier, such digital pregnancy tests and fertility tracking applications, are becoming more and more common. These advances enable people to efficiently manage their reproductive health while maintaining privacy and comfort, which drives market growth by catering to a variety of consumer demands and preferences.
Due to its extensive diagnostic capabilities, biochemical and sediment urinalysis are expected to grow at the quickest rates in the global market for urinalysis tests. A biochemical urinalysis can help identify disorders including diabetes, renal disease, and urinary tract infections by providing information about metabolic and systemic health. In the meantime, the detection of kidney diseases, urinary tract infections, and other renal illnesses is made easier by the useful information that sediment urinalysis offers regarding the composition of urine sediment. The need for precise and effective diagnostic instruments is growing due to the increased incidence of chronic illnesses globally, which is fueling the expansion of these market segments for urine tests.
Analysis by End User
Rapid, automated, and multiparametric urinalysis systems, which have revolutionized hospitals, clinics, and diagnostic labs, are the result of innovations in the global urinalysis test market. These developments improve accuracy, expedite productivity, and decrease turnaround times when detecting infections, chronic illnesses, and urinary tract disorders. Remote monitoring and consultation are made possible by integrated diagnostic solutions with cloud-based connectivity, which facilitates smooth data handling and interpretation. In addition, the increasing focus on early disease identification and preventative healthcare encourages healthcare facilities to use urine testing, which expands the market and enhances patient outcomes.
As biochemical and sediment urinalysis are essential for the diagnosis of a variety of systemic diseases and urinary tract problems, they are expected to grow at the quickest rates in the worldwide urinalysis test market. Biochemical urinalysis helps with early illness identification and surveillance of chronic disorders including diabetes and renal disease by offering important insights into metabolic imbalances, kidney function, and hydration status. Comparably, sediment urinalysis permits microscopic analysis of urine sediment, allowing for the detection of structural and cellular anomalies suggestive of infections, kidney disorders, or blockages of the urinary tract. The market is anticipated to develop significantly because of the anticipated increase in demand for these advanced urinalysis techniques brought about by healthcare professionals' increased emphasis on preventative care and comprehensive diagnostic approaches.
Global Urinalysis Test Market By Test (%)
To get detailed analysis on other segments, Request For Free Sample Report
Urinalysis Test Market Regional Insights
The market for urinalysis tests is dominated by North America due to the rise in chronic kidney and liver illnesses as well as diabetes. During the projected period, the expansion of the urinalysis test market in the area would be further aided by technological advancements. In North America, diabetes is a common chronic illness that is linked to aberrant urine composition. The urinalysis test market is expected to grow significantly in Asia-Pacific because of local enterprises increased technical advancements. The presence of medical equipment businesses in the region and the rise in the purchasing power of populous nations like China and India are responsible for the market's expansion.
Europe, Latin America, and the Middle East and Africa (MEA) regions are seeing notable expansion in the global market for urinalysis tests for several reasons. The European market is expanding due to developments in healthcare infrastructure, growing public awareness of preventative healthcare practices, and rising healthcare costs. The rising incidence of chronic illnesses, better access to healthcare, and rising disposable incomes are driving growth in Latin America. The MEA region's urinalysis test market is expanding quickly due in part to rising healthcare spending, better healthcare infrastructure, and a growing emphasis on early disease identification.
Global Urinalysis Test Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Urinalysis Test Market Dynamics
Drivers
Rising Rates of Diabetes and UTIs
- Rising urinary tract infection (UTI) rates in developing economies are one of the main factors driving the market ahead. Urinary tract infections (UTIs) have the potential to create complications during childbirth and extend to the kidneys if treatment is not received, which could drive market expansion.
Emerging Markets of Urinalysis Test
- Upgrading laboratory infrastructure is crucial given the high frequency of disease, big patient population, growing medical tourism in emerging nations, better healthcare infrastructure, and rising disposable income. To satisfy this need, healthcare infrastructure must be improved as doing so makes medical services and diagnostic tools more accessible.
Restraints
Shortened Urine Analyzers' accessibility
- Cost-effective devices with comparable features are preferred in developing nations as people there are price sensitive. If there aren't strong regulatory structures in place, the economy can see a flood of reconditioned and inferior goods.
Regulatory environment for the urinalysis market
- IVD regulations and laws, which include urinalysis requirements, are getting stricter in the US and Europe. For software updates, the installation of new software on an existing device, or any other modifications made to these devices, new applications could be needed. It poses a significant obstacle to this market's expansion.
Request Free Customization of this report to help us to meet your business objectives.
Urinalysis Test Market Competitive Landscape
Within the highly competitive global urinalysis test market, several multinational corporations hold a dominant position by providing an extensive array of cutting-edge goods and solutions. Abbott Laboratories, Beckman Coulter, Roche Diagnostics, Siemens Healthineers, and Sysmex Corporation are important participants. To be competitive and fulfil the changing needs of customers and healthcare providers around the globe, these organisations concentrate on R&D, strategic alliances, and geographic expansion.
Top Player’s Company Profiles
- Cardinal Health (US)
- General Electric Company (US)
- Metropolis India (India)
- 77 Elektronika Kft (Hungary)
- Roche Diagnostics (Switzerland)
- Thermo Fisher Scientific (US)
- Sysmex Corporation (Japan)
- Abbott (US)
- Trinity Biotech (Ireland)
- ARKRAY Inc. (Japan)
- Dr Lal PathLabs (India)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Siemens (Germany)
- Sysmex Corporation (Japan)
- BioMaxima SA (Poland)
Recent Developments
- In March 2022, the cobas u 701 urine analyzer was introduced by Roche Diagnostics with the goal of streamlining urinalysis procedures thanks to its fully automated operation and extensive testing capabilities. This cutting-edge analyzer offers trustworthy findings for a range of urine parameters, improving the efficiency and accuracy of renal and urinary tract disease diagnosis and monitoring.
- In September 2022, with its state-of-the-art technology, Sysmex Corporation introduced the UD-10 Automated Urine Particle Analyzer, which provides accurate and effective urinalysis. This analyzer enhances diagnostic capacities in clinical laboratories and healthcare facilities globally by providing fast and precise results with its sophisticated imaging and digital processing capabilities.
- In November 2023, With the Atellica 1500 Automated Urinalysis System from Siemens Healthineers, cutting-edge technology is integrated for quick and precise urine analysis. The system provides increased workflow efficiency and high throughput, meeting the growing demand for automated diagnostic solutions in clinical laboratories across the globe.
Urinalysis Test Key Market Trends
- Revolutionizing Urinalysis: The development of diagnostic technology is one of the most significant advances in urine analysis testing. The results of urinalysis are getting better thanks to automated urine analyzers and smartphone-based testing devices. Both patients and medical professionals may now test more easily and simply thanks to these developments. Urinalysis tests become more and more necessary as chronic conditions like diabetes and renal disease progress. The market is growing as urinalysis is useful for treating and keeping track of these conditions. In today's healthcare, urinalysis is essential since it can identify health problems early.
- Enhancing Healthcare Accessibility and Urinalysis Test Efficiency: Notably, point-of-care urinalysis is becoming more and more prevalent. POCT, or point-of-care testing, ensures diagnosis and decision-making at the scene. This is helpful in urgent situations and those that call for prompt action. POCT, or point-of-care testing, is becoming more popular in the medical field due to its simplicity and statistical power. Globally, as more people retire, there is a greater need for diagnostic testing to identify age-related health problems early. Diagnosing renal diseases, diabetes, and UTIs in the elderly with urinalysis enables prompt treatment.
Urinalysis Test Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the need for urinalysis testing is fueled by the increased incidence of urinary tract infections (UTIs) in developing nations, which can have serious consequences if left untreated. To fulfil the enormous demand for diagnostic services, which is being driven by factors including illness prevalence, huge patient populations, rising medical tourism, enhanced healthcare infrastructure, and rising disposable incomes, upgrading laboratory infrastructure is imperative in emerging countries. Price sensitivity in developing nations may favor inexpensive urine analyzers, which could result in an influx of reconditioned and inferior products in the absence of strict regulatory frameworks. Meanwhile, tightening regulations, especially regarding software updates and modifications, will make it difficult for the US and European markets to grow.
Multinational companies like Abbott Laboratories, Beckman Coulter, Roche Diagnostics, Siemens Healthineers, and Sysmex Corporation, which focus on research and development, strategic partnerships, and geographic expansion to meet changing customer and healthcare provider demands worldwide, maintain dominance in the highly competitive global urinalysis test market. The increasing prevalence of chronic conditions like diabetes and renal disease is driving the growing demand for urinalysis tests, which are essential for early detection and treatment, especially with the growing need for diagnostic testing in ageing populations worldwide. The development of diagnostic technology, such as automated urine analyzers and smartphone-based testing devices, is revolutionizing urinalysis, improving accessibility and simplicity for patients and medical professionals.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 2.14 billion |
| Market size value in 2031 | USD 3.09 billion |
| Growth Rate | 4.7% |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Urinalysis Test Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Urinalysis Test Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Urinalysis Test Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Urinalysis Test Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Urinalysis Test Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Urinalysis Test Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
